SPEAKER:
Marcy Witherspoon, LSW
LEARNING OBJECTIVES:
At the end of this training, the learner will be able to:
- Define Motivational Interviewing (MI) and its development as an evidence-based practice.
- Describe the role of Motivational Interviewing in person-centered treatment.
- Discuss common barriers to proper HIV prevention and care and how MI can be applied to empower clients.
- Identify the core principles of motivational interviewing and their application in HIV prevention and care.
- Describe the foundational models and framework of MI and how to identify stages of change in clients.
- Illustrate the use of MI core skills and concepts when speaking with clients to improve adherence and strengthen engagement in care.
- Demonstrate strategies to explore, amplify, and resolve a client’s ambivalence to change using case studies.
- Demonstrate the use of MI approaches in HIV prevention, care, and treatment utilizing OARS and DARN CAT.
- Identify indications of client resistance and strategies to improve readiness to change.
- Apply MI techniques and approaches to client care utilizing real-world scenarios and role-playing.
ACCREDITATION
TBD
CERTIFICATE OF ATTENDANCE:
Please complete a post-evaluation, which will be sent to you via email within 24 hours after the completion of this program from maaetc@pitt.edu. Please note that after completing the evaluation, your general certificate of attendance will be automatically generated and stored in your profile on our website. Simply click my profile, post-event evaluations, and once the training’s evaluation has been completed, you should be able to click the certificate button next to the event to download.
Questions:
Email Tiania Warner, M.S.- twarner@healthfederation.org
ACKNOWLEDGEMENT:
The MidAtlantic AIDS Education and Training Center (MAAETC) is grant-funded by DHHS, Health Resources and Services Administration (HRSA), with an award of $3,463,090.00 and 0% financing from non-governmental sources. Additional funding provided by the Pennsylvania Department of Health (PA DOH), Bureau of Communicable Diseases, Division of HIV Disease. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade names for products mentioned are for training and identification purposes only. The contents of this material are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. Funding was made possible in part by TR7HA53201 from the HRSA, HIV/AIDS Bureau, and the PA DOH. For more information, please visit HRSA.gov.
DISCLAIMER:
Funding for this presentation was made possible in part by TR7HA53201 from the Health Resources and Services Administration HIV/AIDS Bureau. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only.
